Evidence mounts for need to study Pfizer oral antiviral treatment Paxlovid for long COVID: Researchers Ruchika Sharma8 May 2022 10:30 AM ISTPfizer spokesman Kit Longley said company does not have any current long COVID studies underway, but was monitoring data from ongoing clinical studies...
COVID drug makers posting record profits, but treatment out of reach for poor, says WHO MD Bureau8 May 2022 10:00 AM ISTCalling it a "moral failing" Ghebreyesus said that "we cannot accept prices that make life-saving treatments available to the rich and out of reach...
No merit seen in including Paxlovid in Covid treatment: ICMR Roshni Dhar7 May 2022 5:39 PM ISTPfizer's antiviral drug Paxlovid is not going to be included in the national treatment guidelines for Covid-19. Confirmation to this effect was...
COVID vaccine for children: IAP expert comment Ananya Shrivastava7 May 2022 5:34 PM ISTIndian Academy of Paediatrics, twin cities branch, applauded the decision of the Drug Controller General of India (DCGI) which recently approved a...
Health Bulletin 7/May/2022 Roshni Dhar7 May 2022 5:21 PM ISTHere are the top health stories for the day: Postpone NEETPG_Modiji: Doctors launch twitter storm While the Union Health...
NTAGI recommends coronavirus precaution dose before 9 months for those travelling abroad Ruchika Sharma7 May 2022 3:04 PM ISTThe sources further said that no recommendation has been made for reducing the gap in booster doses for everybody.
India stands well prepared to manage increase in coronavirus cases Roshni Dhar7 May 2022 1:57 PM ISTSeveral vaccines along with intranasal and oral drugs have been introduced in the country, over the past year. Several therapeutic options are now...
Paxlovid not be included in national treatment guidelines for COVID-19, says ICMR MD Bureau7 May 2022 1:01 PM ISTExperts from the Indian Council of Medical Research (ICMR) have not found a compelling reason to include the drug in the national treatment guidelines...
AstraZeneca booster effective against severe COVID: UK study Ruchika Sharma7 May 2022 10:00 AM ISTThe research supports the use of the AstraZeneca booster for protection against severe disease with COVID-19 in settings that have not yet offered...
Blood clot risk - USFDA limits use of JnJ COVID vaccine Ruchika Sharma6 May 2022 12:54 PM ISTThe vaccine maker said it has updated the U.S. COVID-19 vaccine fact sheet to warn about the risk of thrombosis with thrombocytopenia syndrome (TTS),...
Double-masking does not improve protection against coronavirus, suggests Study Roshni Dhar5 May 2022 5:40 PM ISTDouble masking with improperly fitted masks may "not significantly improve mask efficiency and produces a false sense of security", suggests the study...
Health Bulletin 5/May/2022 Roshni Dhar5 May 2022 4:58 PM ISTHere are the top health stories for the day: Backdoor entry in medical colleges: Supreme Court issues notice to NMCThe matter...
